The kinetic mechanism of human uridine phosphorylase 1: Towards the development of enzyme inhibitors for cancer chemotherapy

Daiana Renck, Rodrigo G. Ducati, Mario S. Palma, Diógenes S. Santos, Luiz A. Basso

Research output: Contribution to journalArticle

12 Scopus citations


Uridine phosphorylase (UP) is a key enzyme in the pyrimidine salvage pathway, catalyzing the reversible phosphorolysis of uridine to uracil and ribose-1-phosphate (R1P). The human UP type 1 (hUP1) is a molecular target for the design of inhibitors intended to boost endogenous uridine levels to rescue normal tissues from the toxicity of fluoropyrimidine nucleoside chemotherapeutic agents, such as capecitabine and 5-fluorouracil. Here, we describe a method to obtain homogeneous recombinant hUP1, and present initial velocity, product inhibition, and equilibrium binding data. These results suggest that hUP1 catalyzes uridine phosphorolysis by a steady-state ordered bi bi kinetic mechanism, in which inorganic phosphate binds first followed by the binding of uridine, and uracil dissociates first, followed by R1P release. Fluorescence titration at equilibrium showed cooperative binding of either Pi or R1P binding to hUP1. Amino acid residues involved in either catalysis or substrate binding were proposed based on pH-rate profiles.

Original languageEnglish (US)
Pages (from-to)35-42
Number of pages8
JournalArchives of Biochemistry and Biophysics
Issue number1-2
Publication statusPublished - May 1 2010



  • Cancer chemotherapy
  • Fluorescence spectroscopy
  • Initial velocity
  • PH-rate profiles
  • Product inhibition
  • Uridine phosphorylase kinetic mechanism

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology

Cite this